Assessing Claims of Cannabis as an Anti-cancer Agent (CATA)
NCT07107607 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2026-05-07
Summary
The purpose of the study is to find out how cannabis may help control cancer growth by reviewing medical records of patients who report cannabis helped treat their cancer.
Conditions
- Cancer
- Cancer (With or Without Metastasis)
Sponsors & Collaborators
-
HealthPartners Institute
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-03-19
- Primary Completion
- 2027-01-31
- Completion
- 2027-01-31
Countries
- United States
Study Locations
More Related Trials
-
Letrozole Plus Metronomic Capecitabine as First-line Treatment for Patients With Recurrent or Metastatic Breast Cancer
NCT04942899 ·Status: UNKNOWN ·Phase: PHASE2
-
A Clinical Trial in Patients With Breast Cancer Susceptibility Gene (BRCA) Defective Tumours
NCT01432145 ·Status: COMPLETED ·Phase: PHASE2
-
Phase II of Naltrexone in Hormone-Refractory Metastatic Breast Cancer
NCT00379197 ·Status: TERMINATED ·Phase: PHASE2
-
Herbal Therapy in Treating Women With Metastatic Breast Cancer
NCT00028977 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Olaparib in the Treatment of BRCA1/2 Unmutated and BRCA1 Promoter Methylated Recurrent and Metastatic Triple-negative Breast Cancer
NCT05522491 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Cabozantinib for Metastatic Triple Negative BrCa
NCT01738438 ·Status: COMPLETED ·Phase: PHASE2
-
Cetuximab + / - Carboplatin for Estrogen Receptor-Negative, Progesterone Receptor-Negative Metastatic Breast Cancer
NCT00232505 ·Status: COMPLETED ·Phase: PHASE2
-
C11 AMT Positron Emission Tomography (PET) Imaging in Patients With Metastatic Invasive Breast Cancer
NCT01302821 ·Status: WITHDRAWN ·Phase: NA
-
Phase II Study of Irinotecan/Capecitabine in Patients With Antracycline/Taxane Pretreated MBC
NCT00532714 ·Status: COMPLETED ·Phase: PHASE2
-
Intrathecal Pertuzumab and Trastuzumab in Patients With New Untreated Asymptomatic or Low Symptomatic Brain Metastasis in HER2 Positive Breast Cancer
NCT02598427 ·Status: TERMINATED ·Phase: PHASE1
-
BP-C1 in Metastatic Breast Cancer Patients
NCT01861509 ·Status: COMPLETED ·Phase: PHASE1
-
A Research Study of CP-724,714 in Patients With HER2 Overexpressing Metastatic Breast Cancer
NCT00102895 ·Status: TERMINATED ·Phase: PHASE2
-
Celecoxib in Treating Women With Metastatic or Recurrent Breast Cancer
NCT00045591 ·Status: TERMINATED ·Phase: PHASE2
-
Oral Metronomic Capecitabine Combined With Pyrotinib in ADC-treated HER2-positive Metastatic Breast Cancer
NCT07019337 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Phase I of Carboplatin-Olaparib Followed by Olaparib Monotherapy in Advanced Cancer
NCT02418624 ·Status: COMPLETED ·Phase: PHASE1
-
Phase II Study of Capecitabine and Cisplatin to Treat Metastatic Triple Negative Breast Cancer
NCT01928680 ·Status: UNKNOWN ·Phase: PHASE2
-
Study Of Single-dose Cyclophosphamide +Pembrolizumab In Patients With Metastatic Triple Negative Breast Cancer
NCT02768701 ·Status: COMPLETED ·Phase: PHASE2
-
A Prospective, Multicenter, Observational Cohort Study to Evaluate the Efficacy and Safety of a Novel Anti-tumor Drug As a Radiosensitizer in Patients with Advanced Breast Cancer Brain Metastasis.
NCT06839547 ·Status: NOT_YET_RECRUITING
-
Clodronate With or Without Chemotherapy and/or Hormonal Therapy in Treating Women With Stage I or Stage II Breast Cancer
NCT00009945 ·Status: COMPLETED ·Phase: PHASE3
-
Capecitabine in Low Risk Triple Negative Breast Cancer
NCT06787339 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Metabolomics Explores Biomarkers for Metastatic Breast Cancer
NCT04302415 ·Status: UNKNOWN
-
Mechanisms of Response and Resistance to Innovative Treatments in Patients With Locally Advanced or Metastatic Breast Cancer
NCT07066917 ·Status: RECRUITING
-
A Study of Biweekly Pemetrexed and Gemcitabine in Patients With Metastatic Breast Cancer
NCT00191347 ·Status: COMPLETED ·Phase: PHASE2
-
Irinotecan and Capecitabine in Treating Women With Advanced Breast Cancer
NCT00083148 ·Status: COMPLETED ·Phase: PHASE1
-
Management of Metastatic Breast Cancer in Frail Patients
NCT00005614 ·Status: WITHDRAWN ·Phase: PHASE2